Seiji Okada

40PUBLICATIONS
82CO-AUTHORS
Molecular targetsImmunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)Prosthetics and orthoticsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 20, 2026
Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma.

|Apr 08, 2026
A novel hairless highly immunodeficient mice model optimized for in vivo imaging.

Kouki Matsuda, Ryusho Kariya, Sawako Fujikawa

|Apr 02, 2026
IL-6-driven POU2AF1 and ELL2 are key regulators of multiple myeloma-distinct transcriptional and splicing programs.

Yasuyo Ohguchi, Masahiko Ajiro, Daisuke Ogiya

|Aug 11, 2025
High cyclic GMP-AMP synthase and stimulator of interferon genes in cholangiocarcinoma suggest their potential as targets for treatment.

Han Ni Zin Myint, Paksiree Saranaruk, Natnicha Paungpan

|Jul 30, 2025
Current State of AIDS-Related Malignant Lymphoma.

Seiji Okada, Shotaro Hagiwara, Hirokazu Nagai

|Jun 03, 2025
Establishment and characterization of TK-DDCS1: a novel IDH1 mutated dedifferentiated chondrosarcoma cell line.

Krittamate Saisuwan, Piyanard Boonnate, Hiroki Goto

Pageof 7

Frequent Collaborators

3 joint publications

Kulthida Vaeteewoottacharn

3 joint publications

Jutatip Panaampon

2 joint publications

Chaisiri Wongkham

2 joint publications

Kaoru Hirabayashi